DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

未开盘 04-30 16:00:00 EDT

9.01

-0.07

-0.77%

盘后9.01

+0.000.00%

18:24 EDT

最高9.45	最低8.77	成交量4.74万
今开8.90	昨收9.08	日振幅7.49%
总市值2.46亿	流通市值1.30亿	总股本2,734万
成交额43.23万	换手率0.33%	流通股本1,447万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":9.01,"timestamp":1746043200000,"preClose":9.08,"halted":0,"volume":47375,"hourTrading":{"tag":"盘后","latestPrice":9.01,"preClose":9.01,"latestTime":"18:24 EDT","volume":6,"amount":54.06,"timestamp":1746051875891},"delay":0,"floatShares":14467200,"shares":27336400,"eps":-5.87234,"marketStatus":"未开盘","change":-0.07,"latestTime":"04-30 16:00:00 EDT","open":8.9,"high":9.445,"low":8.765,"amount":432271.2925,"amplitude":0.07489,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.87234,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746086400000},"marketStatusCode":0,"adr":1,"adrRate":5,"listingDate":1413950400000,"exchange":"NASDAQ","adjPreClose":9.08,"preHourTrading":{"tag":"盘前","latestPrice":8.89,"preClose":9.08,"latestTime":"08:54 EDT","volume":36,"amount":320.320026,"timestamp":1746017697665},"postHourTrading":{"tag":"盘后","latestPrice":9.01,"preClose":9.01,"latestTime":"18:24 EDT","volume":6,"amount":54.06,"timestamp":1746051875891},"volumeRatio":0.395453,"impliedVol":4.0465,"impliedVolPercentile":0.9643},"requestUrl":"/m/hq/s/DBVT","defaultTab":"news","newsList":[{"id":"2531372792","title":"Dbv Technologies盘中异动 急速拉升5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531372792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531372792?lang=zh_cn&edition=full","pubTime":"2025-04-29 00:39","pubTimestamp":1745858372,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日00时39分，Dbv Technologies股票出现异动，股价急速拉升5.39%。截至发稿，该股报8.99美元/股，成交量3.1488万股，换手率0.12%，振幅7.56%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.59%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429003932a46ac0c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429003932a46ac0c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2530415980","title":"Dbv Technologies盘中异动 临近午盘股价大涨5.06%报9.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530415980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530415980?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:30","pubTimestamp":1745595046,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日23时30分，Dbv Technologies股票出现波动，股价快速上涨5.06%。截至发稿，该股报9.35美元/股，成交量2.4203万股，换手率0.09%，振幅2.25%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.29%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425233046a466fae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425233046a466fae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2529658699","title":"Dbv Technologies盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529658699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529658699?lang=zh_cn&edition=full","pubTime":"2025-04-24 00:44","pubTimestamp":1745426681,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日00时44分，Dbv Technologies股票出现波动，股价大幅上涨5.26%。截至发稿，该股报9.21美元/股，成交量14.7651万股，换手率0.54%，振幅7.43%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.53%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424004441a6c56a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424004441a6c56a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2529705381","title":"Dbv Technologies盘中异动 早盘大幅上涨6.39%报8.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529705381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529705381?lang=zh_cn&edition=full","pubTime":"2025-04-21 23:25","pubTimestamp":1745249149,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时25分，Dbv Technologies股票出现异动，股价大幅拉升6.39%。截至发稿，该股报8.49美元/股，成交量8183股，换手率0.03%，振幅7.71%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.07%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421232550a6c28e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421232550a6c28e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2528477386","title":"Dbv Technologies盘中异动 临近收盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528477386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528477386?lang=zh_cn&edition=full","pubTime":"2025-04-18 04:00","pubTimestamp":1744920017,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日04时00分，Dbv Technologies股票出现波动，股价快速拉升5.56%。截至发稿，该股报8.35美元/股，成交量3.878万股，换手率0.14%，振幅4.42%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.97%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418040017a6be61e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418040017a6be61e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2528422142","title":"Dbv Technologies盘中异动 股价大涨6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528422142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528422142?lang=zh_cn&edition=full","pubTime":"2025-04-17 00:13","pubTimestamp":1744820010,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日00时13分，Dbv Technologies股票出现异动，股价大幅上涨6.77%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.14%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417001330a45b51bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417001330a45b51bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2527417551","title":"Dbv Technologies盘中异动 早盘快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527417551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527417551?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:32","pubTimestamp":1744723930,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时32分，Dbv Technologies股票出现波动，股价快速下跌5.10%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.07%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213210a6bb4b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213210a6bb4b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2527198905","title":"Dbv Technologies盘中异动 早盘股价大涨5.19%报7.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527198905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527198905?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:25","pubTimestamp":1744640728,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时25分，Dbv Technologies股票出现异动，股价急速上涨5.19%。截至发稿，该股报7.70美元/股，成交量1.6385万股，换手率0.06%，振幅4.34%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.31%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414222528aa2c6e8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414222528aa2c6e8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2518272635","title":"Dbv Technologies盘中异动 股价大涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272635?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:30","pubTimestamp":1741613459,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时30分，Dbv Technologies股票出现波动，股价快速上涨8.25%。截至发稿，该股报4.52美元/股，成交量4.8497万股，换手率0.24%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2517166262","title":"Dbv Technologies盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166262?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:51","pubTimestamp":1741272707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时51分，Dbv Technologies股票出现异动，股价快速跳水5.63%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.67%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2517910072","title":"Dbv Technologies盘中异动 股价大跌5.35%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910072?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185043,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Dbv Technologies股票出现异动，股价大幅跳水5.35%。截至发稿，该股报4.07美元/股，成交量365股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2517098348","title":"Dbv Technologies盘中异动 下午盘大幅拉升8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517098348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517098348?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:49","pubTimestamp":1741117758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时49分，Dbv Technologies股票出现波动，股价大幅拉升8.33%。截至发稿，该股报4.29美元/股，成交量6073股，换手率0.03%，振幅5.05%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2516341226","title":"Dbv Technologies盘中异动 股价大跌8.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516341226?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012404,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Dbv Technologies股票出现波动，股价急速跳水8.99%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.21%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2514202563","title":"Dbv Technologies盘中异动 早盘股价大跌6.43%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514202563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514202563?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:43","pubTimestamp":1740753830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时43分，Dbv Technologies股票出现异动，股价急速下挫6.43%。截至发稿，该股报3.93美元/股，成交量4017股，换手率0.02%，振幅0.41%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2513722215","title":"Dbv Technologies盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722215?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:41","pubTimestamp":1740408083,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时41分，Dbv Technologies股票出现波动，股价大幅下挫5.35%。截至发稿，该股报4.16美元/股，成交量2295股，换手率0.01%，振幅0.91%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.06%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2513215896","title":"Dbv Technologies盘中异动 股价大涨7.98%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513215896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513215896?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:54","pubTimestamp":1740160498,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时54分，Dbv Technologies股票出现异动，股价大幅拉升7.98%。截至发稿，该股报4.60美元/股，成交量4995股，换手率0.02%，振幅9.15%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.44%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015458abd7daaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015458abd7daaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2511487525","title":"Dbv Technologies盘中异动 股价大涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511487525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511487525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457148,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Dbv Technologies股票出现波动，股价大幅拉升6.11%。截至发稿，该股报4.37美元/股，成交量625股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223228abcdb26b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223228abcdb26b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2510351579","title":"Dbv Technologies盘中异动 下午盘急速拉升6.65%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510351579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510351579?lang=zh_cn&edition=full","pubTime":"2025-02-12 03:54","pubTimestamp":1739303644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日03时54分，Dbv Technologies股票出现异动，股价快速拉升6.65%。截至发稿，该股报4.47美元/股，成交量9791股，换手率0.05%，振幅9.87%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.75%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212035404961f7be0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212035404961f7be0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2509200387","title":"Dbv Technologies盘中异动 大幅跳水6.44%报4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509200387?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:26","pubTimestamp":1738866417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时26分，Dbv Technologies股票出现波动，股价快速跳水6.44%。截至发稿，该股报4.29美元/股，成交量1.6438万股，换手率0.08%，振幅1.53%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.19%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022657a23bfed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022657a23bfed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2508457616","title":"Dbv Technologies盘中异动 早盘快速拉升9.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457616?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:30","pubTimestamp":1738679425,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时30分，Dbv Technologies股票出现波动，股价大幅拉升9.36%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223025987a4a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223025987a4a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com","stockEarnings":[{"period":"1week","weight":0.0377},{"period":"1month","weight":0.4645},{"period":"3month","weight":1.1517},{"period":"6month","weight":1.333},{"period":"1year","weight":0.3137},{"period":"ytd","weight":1.9385}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.该公司于2002年3月29日根据法兰西共和国法律注册成立。该公司是一家临床阶段的专业生物制药公司，专注于通过开发名为Viaskin的新型技术平台来改变免疫治疗领域。该公司的治疗方法基于表皮免疫疗法，即EPIT，这是其使用Viaskin通过完整皮肤向免疫系统递送生物活性化合物的专有方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":0.055168},{"month":2,"riseRate":0.545455,"avgChangeRate":0.001105},{"month":3,"riseRate":0.545455,"avgChangeRate":0.05101},{"month":4,"riseRate":0.636364,"avgChangeRate":0.095908},{"month":5,"riseRate":0.3,"avgChangeRate":-0.01824},{"month":6,"riseRate":0.3,"avgChangeRate":0.029895},{"month":7,"riseRate":0.5,"avgChangeRate":0.073589},{"month":8,"riseRate":0.3,"avgChangeRate":-0.04708},{"month":9,"riseRate":0.2,"avgChangeRate":-0.097377},{"month":10,"riseRate":0.1,"avgChangeRate":-0.171829},{"month":11,"riseRate":0.545455,"avgChangeRate":0.026648},{"month":12,"riseRate":0.636364,"avgChangeRate":-0.022382}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}